GTR 110624211
Bids Are Invited For Acquisition Of Oncology Medications To Meet The Needs Of Patients Served By The Hgun Oncology Center.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
110624211
Tendering Authority
Subscribe to view
Tender No
90020/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Oncology Medications To Meet The Needs Of Patients Served By The Hgun Oncology Center.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
31-03-2026
Closed
Work Detail
Acquisition Of Oncology Medications To Meet The Needs Of Patients Served By The Hgun Oncology Center.. Abatacept, Abemaciclib, Abiraterone Acetate, Acalabrutinib, Goserelin Acetate, Goserelin Acetate, Zoledronic Acid, Afatinib Dimaleate, Afatinib Dimaleate,Alectinib,Alpelisib,Anastrozole,Apalutamide,Atezolizumab,Avelumab,Axitinib,Axitinib,Azacitidine,Bevacizumab,Bevacizumab,Bicalutamide,Bleomycin Sulfate,Blinatumomab,Bortezomib,Brentuximab Vedotin,Brigatinib,Brigatinib,Cabazitaxel,Cabergoline,Cabozantinib,Cabozantinib,Cabozantinib,Carfilzomib,Capecitabine,Capmatinib,Capmatinib,Carboxymaltose Ferrica,Carboplatin,Carboplatin,Cemiplimab,Cetuximab,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cisplatin,Cytarabine,Cytarabine,Chlorambucil,Cobimetinib Hemifumarate,Crizotinib,Crizotinib,Dabrafenib,Dabrafenib,Dacarbazine,Daratumumab,Daratumumab,Daratumumab,Darolutamide,Dasatinib,Dasatinib,Degarelix,Degarelix,Denosumab,Docetaxel,Doxorubicin Hydrochloride,Doxorubicin Hydrochloride,Durvalumab,Durvalumab,Enfortumab,Enfortumab,Enzalutamide,Epcoritamab,Epcoritamab,Erdafitinib,Erdafitinib,Erdafitinib,Eribulin Mesylate,Erlotinib,Etoposide,Everolimus,Everolimus,Exemestane,Fexofenadine,Filgrastim,Fingolimod Hydrochloride,Fluoruracil,Fluoruracil,Calcium Folinate,Fosaprepitant Dimeglumine,Gefitinib,Gemcitabine Hydrochloride,Gemcitabine Hydrochloride,Gilteritinib,Hydroxyurea,Ibrutinib,Ifosfamide,Ifosfamide,Infliximab,Imatinib Mesylate,Probiotic
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
60f327f2-1e06-4f03-88fe-de28ccce8a39.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.